Final Results of the Phase 1/2 Study of Acalabrutinib Monotherapy in Treatment-Naive Chronic Lymphocytic Leukemia with >6 Years of Follow-up

Authors :: John C. Byrd
Jennifer A. Woyach
Richard R. Furman
Peter Martin
Susan O'Brien
Jennifer R. Brown
Deborah M. Stephens
Jacqueline C. Barrientos
Piers EM Patten
Talha Munir
Krish Patel
Anna Butturini
Marianne de Borja
Min Hui Wang
Nitin Jain
William G. Wierda
Source :: Blood. 140:9865-9867
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools